The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The drug is being developed at lab scale for the first-line of treatment of Covid-19
The company has strong product launches both in India and overseas
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Subscribe To Our Newsletter & Stay Updated
